BRANDYWINE MANAGERS, LLC - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 223 filers reported holding 10X GENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.25 and the average weighting 1.5%.

Quarter-by-quarter ownership
BRANDYWINE MANAGERS, LLC ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$462,330
-26.1%
11,2080.0%0.78%
+88.9%
Q2 2023$625,855
+0.1%
11,2080.0%0.41%
-7.0%
Q1 2023$625,294
+53.1%
11,2080.0%0.44%
-68.9%
Q4 2022$408,420
+28.0%
11,2080.0%1.43%
+36.0%
Q3 2022$319,000
-14.5%
11,208
+36.0%
1.05%
+14.8%
Q2 2022$373,000
-40.5%
8,2410.0%0.91%
-15.5%
Q1 2022$627,000
-41.7%
8,241
+14.2%
1.08%
-11.2%
Q4 2021$1,075,000
+2.3%
7,2170.0%1.22%
+11.0%
Q3 2021$1,051,000
-25.6%
7,2170.0%1.10%
-31.9%
Q2 2021$1,413,000
+8.2%
7,2170.0%1.61%
-7.2%
Q1 2021$1,306,000
+114.4%
7,217
+67.8%
1.74%
+107.2%
Q4 2020$609,000
+13.6%
4,3000.0%0.84%
-17.6%
Q3 2020$536,000
+39.6%
4,3000.0%1.02%
-35.5%
Q2 2020$384,000
+43.3%
4,3000.0%1.58%
+1577.7%
Q1 2020$268,000
-18.3%
4,3000.0%0.09%
-4.1%
Q4 2019$328,000
+51.2%
4,3000.0%0.10%
+34.2%
Q3 2019$217,0004,3000.07%
Other shareholders
10X GENOMICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 1,358,528$49,504,760100.00%
Meritech Capital Associates V L.L.C. 1,061,682$38,687,6929.44%
Decheng Capital Management III (Cayman), LLC 359,554$13,102,1484.90%
Sands Capital Ventures, LLC 481,770$17,5564.81%
Whitford Management LLC 58,310$2,124,8032.88%
FINANCIAL CONSULATE, INC 156,457$5,701,2931.99%
SRS Investment Management, LLC 3,005,427$109,517,7601.98%
BRANDYWINE MANAGERS, LLC 11,208$408,4201.43%
ARK Investment Management 4,316,567$157,295,7011.36%
Nikko Asset Management Americas, Inc. 2,177,988$79,365,8831.14%
View complete list of 10X GENOMICS INC shareholders